Treatment Study for Cognitive Deficits in Schizophrenia

NCT00505076 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MK-0777
DRUG: MK-0777
DRUG: placebo

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]